𝔖 Bobbio Scriptorium
✦   LIBER   ✦

[Lys(B28), Pro(B29)]-Human Insulin: A Rapidly Absorbed Analogue of Human Insulin

✍ Scribed by Howey, D. C.; Bowsher, R. R.; Brunelle, R. L.; Woodworth, J. R.

Book ID
121748098
Publisher
American Diabetes Association
Year
1994
Tongue
English
Weight
892 KB
Volume
43
Category
Article
ISSN
0012-1797

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Human insulin analogue [LYS(B28), PRO(B2
Human insulin analogue [LYS(B28), PRO(B29)]: the ideal pump insulin?
✍ SchmauΞ², S.; KΓΆnig, A.; Landgraf, R. πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 50 KB

The short-acting insulin analogue lispro ([LYS(B28), PRO(B29)] is absorbed from the subcutis more rapidly than soluble insulin (S). To compare the clinical effectiveness of lispro vs S, 11 Type 1 patients using continuous subcutaneous insulin infusion (CSII) therapy (6 F, 5 M, age 30 +/- 2.5 years,

Counterregulatory Hormone Responses and
Counterregulatory Hormone Responses and Symptoms During Hypoglycaemia Induced by Porcine, Human Regular Insulin, and Lys(B28), Pro(B29) Human Insulin Analogue (Insulin Lispro) in Healthy Male Volunteers
✍ Jacobs, M.A.J.M.; Salobir, B.; Popp-Snijders, C.; Ader, H.; Heine, R.J. πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 278 KB πŸ‘ 2 views

Lys(B28)Pro(B29) human insulin analogue (Lispro) is a newly developed monomeric insulin analogue with a rapid onset and short duration of action. The aim of the study was to compare the thresholds for the counterregulatory responses during a stepwise euglycaemic/hypoglycaemic clamp for insulin lispr

Pharmacokinetics, pharmacodynamics and g
Pharmacokinetics, pharmacodynamics and glucose counterregulation following subcutaneous injection of the monomeric insulin analogue [Lys(B28),Pro(B29)] in IDDM
✍ E. Torlone; C. Fanelli; A. M. Rambotti; G. Kassi; F. Modarelli; A. Di Vincenzo; πŸ“‚ Article πŸ“… 1994 πŸ› Springer 🌐 English βš– 841 KB

The aim of these studies was to compare the pharmacokinetics, pharmacodynamics, counterregulatory hormone and symptom responses, as well as cognitive function during hypoglycaemia induced by s.c. injection of 0.15 IU/kg of regular human insulin (HI) and the monomeric insulin analogue [Lys(B28),Pro (